Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial - Reardon, DA; Brandes, AA; Omuro, A; Mulholland, P; Lim, M; Wick, A (JAMA Oncol, 2020)